Literature DB >> 15780077

Analysis of NPHS1, NPHS2, ACTN4, and WT1 in Japanese patients with congenital nephrotic syndrome.

Mayumi Sako1, Koichi Nakanishi, Mina Obana, Nahoko Yata, Sakurako Hoshii, Shori Takahashi, Naohiro Wada, Yasuhiko Takahashi, Yoshitsugu Kaku, Kenichi Satomura, Masahiro Ikeda, Masataka Honda, Kazumoto Iijima, Norishige Yoshikawa.   

Abstract

BACKGROUND: Congenital nephrotic syndrome (CNS) causes significant renal failure, and is classified into two types: (1) Finnish type; and (2) other, including diffuse mesangial sclerosis. Mutations of NPHS1 and NPHS2, which encode the slit diaphragm components nephrin and podocin, cause CNS and autosomal-recessive familial steroid-resistant nephrotic syndrome, respectively. Most patients with Finnish-type CNS in Europe and the United States have NPHS1 mutations. However, NPHS2 mutations have been detected in some cases. Mutations in ACTN4, encoding alpha-actinin-4, cause an autosomal-dominant focal segmental glomerulosclerosis. alpha-actinin-4 stabilizes the podocyte cytoskeleton structure, connecting with actin filaments. WT1 mutations, causing Wilm's tumor, have been demonstrated in some CNS patients with diffuse mesangial sclerosis. Systematic investigation of genes for CNS in Japan has never been performed.
METHODS: To clarify the role of mutations in these four genes, we used polymerase chain reaction (PCR) and direct sequencing to investigate all exons and exon-intron boundaries for these genes in 13 unrelated CNS patients from regional pediatric kidney disease centers in Japan.
RESULTS: A novel homozygous nonsense mutation of NPHS1, E246X in exon 7, and a novel homozygous deletion mutation of NPHS1, 2156_2163del in exon 16 were detected in one patient each. A novel homozygous nonsense mutation of NPHS2, R196X in exon 5, was found in one patient, and the same heterozygous nonsense mutation was detected in another. No ACTN4 or WT1 mutations were detected.
CONCLUSION: These studies demonstrate that mutation of NPHS1 is not a major cause of CNS in Japanese patients, and that mutation of NPHS2 can be responsible for CNS in this population.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15780077     DOI: 10.1111/j.1523-1755.2005.00202.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  31 in total

1.  Genotype-phenotype correlations in non-Finnish congenital nephrotic syndrome.

Authors:  Eduardo Machuca; Geneviève Benoit; Fabien Nevo; Marie-Josèphe Tête; Olivier Gribouval; Audrey Pawtowski; Per Brandström; Chantal Loirat; Patrick Niaudet; Marie-Claire Gubler; Corinne Antignac
Journal:  J Am Soc Nephrol       Date:  2010-05-27       Impact factor: 10.121

2.  Reevaluation of glomerular charge selective protein-sieving function.

Authors:  Hiroshi Saito; Shori Takahashi; Michio Nagata; Tatsuyuki Tsuchiya; Hideo Mugishima; Kunimasa Yan; Yoshiaki Kondo; Takeshi Matsuyama; Takashi Sekine; Takashi Igarashi
Journal:  Pediatr Nephrol       Date:  2008-10-29       Impact factor: 3.714

3.  Long-term outcome of congenital nephrotic syndrome after kidney transplantation in Japan.

Authors:  Yuko Hamasaki; Masaki Muramatsu; Riku Hamada; Kenji Ishikura; Hiroshi Hataya; Hiroyuki Satou; Masataka Honda; Koichi Nakanishi; Seiichiro Shishido
Journal:  Clin Exp Nephrol       Date:  2017-11-28       Impact factor: 2.801

4.  Mutation-dependent recessive inheritance of NPHS2-associated steroid-resistant nephrotic syndrome.

Authors:  Kálmán Tory; Dóra K Menyhárd; Stéphanie Woerner; Fabien Nevo; Olivier Gribouval; Andrea Kerti; Pál Stráner; Christelle Arrondel; Evelyne Huynh Cong; Tivadar Tulassay; Géraldine Mollet; András Perczel; Corinne Antignac
Journal:  Nat Genet       Date:  2014-02-09       Impact factor: 38.330

5.  Familial steroid-sensitive nephrotic syndrome in Southern Israel: clinical and genetic observations.

Authors:  Daniel Landau; Tal Oved; Dan Geiger; Luba Abizov; Hanna Shalev; Ruti Parvari
Journal:  Pediatr Nephrol       Date:  2007-01-12       Impact factor: 3.714

6.  Novel mutations in steroid-resistant nephrotic syndrome diagnosed in Tunisian children.

Authors:  Ibtihel Benhaj Mbarek; Saoussen Abroug; Asma Omezzine; Audrey Pawtowski; Marie Claire Gubler; Ali Bouslama; Abdelaziz Harbi; Corinne Antignac
Journal:  Pediatr Nephrol       Date:  2010-12-02       Impact factor: 3.714

7.  Steroid-resistant nephrotic syndrome caused by co-inheritance of mutations at NPHS1 and ADCK4 genes in two Chinese siblings.

Authors:  Hongwen Zhang; Fang Wang; Xiaoyu Liu; Xuhui Zhong; Yong Yao; Huijie Xiao
Journal:  Intractable Rare Dis Res       Date:  2017-11

8.  Analysis of recessive CD2AP and ACTN4 mutations in steroid-resistant nephrotic syndrome.

Authors:  Geneviève Benoit; Eduardo Machuca; Fabien Nevo; Olivier Gribouval; David Lepage; Corinne Antignac
Journal:  Pediatr Nephrol       Date:  2009-12-03       Impact factor: 3.714

9.  Epithelial-to-mesenchymal transition is a potential pathway leading to podocyte dysfunction and proteinuria.

Authors:  Yingjian Li; Young Sun Kang; Chunsun Dai; Lawrence P Kiss; Xiaoyan Wen; Youhua Liu
Journal:  Am J Pathol       Date:  2008-01-17       Impact factor: 4.307

10.  Wnt/beta-catenin signaling promotes podocyte dysfunction and albuminuria.

Authors:  Chunsun Dai; Donna B Stolz; Lawrence P Kiss; Satdarshan P Monga; Lawrence B Holzman; Youhua Liu
Journal:  J Am Soc Nephrol       Date:  2009-07-23       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.